Code Name | Research | Pre-Clinical | Clinical trial | |||
---|---|---|---|---|---|---|
Indication | Discovery Research | PCC | PC/tox | P1 | P2 | P3 |
SE101 | ||||||
Anti-Cancer Combi. |
Combination with anti-cancer chemo-therapy |
|||||
SE102 |
Collaboration research with Senelix Co. |
|||||
Dry Eye Syndrome |
|
|||||
SE103 |
|
|||||
Anti-Obesity |
|
|||||
SE201 |
|
|||||
Anti-Cancer Combi. |
Combination with anti-cancer chemo-therapy |
|||||
SE301 |
Binterin™, and Winhibin™
Investigator-initiated clinical trial
|
|||||
Hand-Foot Syndrome |
Mechanism research of HFS inhibition |